FAM72A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.934000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.524400E-01
Normal-vs-Stage2
7.178800E-01
Normal-vs-Stage3
6.698600E-01
Normal-vs-Stage4
8.641600E-01
Stage1-vs-Stage2
5.456200E-01
Stage1-vs-Stage3
5.427000E-01
Stage1-vs-Stage4
7.297000E-01
Stage2-vs-Stage3
3.123600E-01
Stage2-vs-Stage4
8.948600E-01
Stage3-vs-Stage4
4.347800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.757800E-01
Normal-vs-AfricanAmerican
9.735200E-01
Normal-vs-Asian
8.130000E-01
Caucasian-vs-AfricanAmerican
7.319000E-01
Caucasian-vs-Asian
9.110400E-01
AfricanAmerican-vs-Asian
7.942400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.790200E-01
Normal-vs-Female
8.115400E-01
Male-vs-Female
9.186000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.893000E-01
Normal-vs-Age(41-60Yrs)
7.109200E-01
Normal-vs-Age(61-80Yrs)
8.494800E-01
Normal-vs-Age(81-100Yrs)
6.533400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.031200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.083800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.593550E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.989200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.628400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.889200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.591800E-01
Normal-vs-Daily Drinker
9.808200E-01
Normal-vs-Weekly Drinker
6.264400E-01
Normal-vs-Occasional Drinker
7.224600E-01
Normal-vs-Social Drinker
8.680600E-01
Non Drinker-vs-Daily Drinker
4.249600E-01
Non Drinker-vs-Weekly Drinker
8.219000E-01
Non Drinker-vs-Occasional Drinker
8.344800E-01
Non Drinker-vs-Social Drinker
5.895200E-01
Daily Drinker-vs-Weekly Drinker
2.813200E-01
Daily Drinker-vs-Occasional Drinker
4.767800E-01
Daily Drinker-vs-Social Drinker
7.736600E-01
Weekly Drinker-vs-Occasional Drinker
6.316400E-01
Weekly Drinker-vs-Social Drinker
4.423400E-01
Occasional Drinker-vs-Social Drinker
6.952000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
7.789100E-04
Grade 1-vs-Grade 3
3.798700E-04
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
1.676790E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.210400E-01
Normal-vs-NonDiabetic
7.612000E-01
Diabetic-vs-NonDiabetic
2.009600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.252400E-01
Normal-vs-NoPancreatitis
8.584000E-01
Pancreatitis-vs-NoPancreatitis
1.650030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.137000E-01
Normal-vs-N1
7.556600E-01
N0-vs-N1
5.426600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.800560E-01
Normal-vs-TP53-NonMutant
9.307400E-01
TP53-Mutant-vs-TP53-NonMutant
7.22709999956272E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
